Liraglutide trial for Knee Osteoarthritis-4P004
-
A new trial for Knee Osteoarthritis:
Summary: FDA fast tracks 4P004, The FDA has granted Fast Track status to 4P004, an intra‑articular GLP‑1 receptor agonist (liraglutide) being developed for knee osteoarthritis with synovitis, specifically for patients who have already failed two or more prior drug therapies
Very interesting info, says GLPs have shown chondroprotective properties.
-
They’ll be putting it in the water eventually. And my brother will still say they aren’t safe.

-
A new trial for Knee Osteoarthritis:
Summary: FDA fast tracks 4P004, The FDA has granted Fast Track status to 4P004, an intra‑articular GLP‑1 receptor agonist (liraglutide) being developed for knee osteoarthritis with synovitis, specifically for patients who have already failed two or more prior drug therapies
Very interesting info, says GLPs have shown chondroprotective properties.
@WisGal64 saw a write up called "Functional peptides for cartilage repair and regeneration"
tldr they were talking about tb500 and bpc 157 along with aod 9604.
its also written again in "Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis" with the same above along with one ive never heard of called pps elmiron. both on the national library of medicine page.
worth a gander id say. -
@quicksilver80 thanks will check it out
-
A new trial for Knee Osteoarthritis:
Summary: FDA fast tracks 4P004, The FDA has granted Fast Track status to 4P004, an intra‑articular GLP‑1 receptor agonist (liraglutide) being developed for knee osteoarthritis with synovitis, specifically for patients who have already failed two or more prior drug therapies
Very interesting info, says GLPs have shown chondroprotective properties.
-
Is this available in grey?
-
I have some on the way for my old horse knees. Trying to prevent having my other knee replaced.